These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25844960)

  • 1. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Whiteoak SR; Felwick R; Sanchez-Elsner T; Fraser Cummings JR
    Inflamm Bowel Dis; 2015 May; 21(5):1160-5. PubMed ID: 25844960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MiRNAs in Inflammatory Bowel Disease.
    Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
    Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: how many in inflammatory bowel disease?
    Schaefer JS
    Curr Opin Gastroenterol; 2016 Jul; 32(4):258-66. PubMed ID: 27138057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].
    Igaz I; Szőnyi M; Varga P; Topa L
    Orv Hetil; 2014 Mar; 155(13):487-91. PubMed ID: 24659741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
    Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
    World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNAs and inflammatory bowel disease: An interesting new story.
    Moein S; Vaghari-Tabari M; Qujeq D; Majidinia M; Nabavi SM; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3277-3293. PubMed ID: 30417350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of variations within microRNA in inflammatory bowel disease.
    Papaconstantinou I; Stamatis K; Tzathas C; Vassiliou I; Giokas G; Gazouli M
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):399-403. PubMed ID: 23466513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
    Fisher K; Lin J
    World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
    Hübenthal M; Hemmrich-Stanisak G; Degenhardt F; Szymczak S; Du Z; Elsharawy A; Keller A; Schreiber S; Franke A
    PLoS One; 2015; 10(10):e0140155. PubMed ID: 26466382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of micro-ribonucleic acid in disease development].
    Widjaya B; Seidelin JB; Olsen J; Nielsen OH
    Ugeskr Laeger; 2009 Nov; 171(47):3441-4. PubMed ID: 19925731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.
    De Iudicibus S; Lucafò M; Martelossi S; Pierobon C; Ventura A; Decorti G
    World J Gastroenterol; 2013 Nov; 19(44):7947-54. PubMed ID: 24307788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in inflammatory bowel disease.
    Pekow JR; Kwon JH
    Inflamm Bowel Dis; 2012 Jan; 18(1):187-93. PubMed ID: 21425211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
    Jiang W; Li X
    Mol Diagn Ther; 2015 Jun; 19(3):141-58. PubMed ID: 25990388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.
    Iborra M; Bernuzzi F; Invernizzi P; Danese S
    Autoimmun Rev; 2012 Mar; 11(5):305-14. PubMed ID: 20627134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.
    Tomankova T; Petrek M; Gallo J; Kriegova E
    Scand J Immunol; 2012 Feb; 75(2):129-41. PubMed ID: 21988491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Boros É; Nagy I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs as biomarkers for inflammatory diseases.
    Mi S; Zhang J; Zhang W; Huang RS
    Microrna; 2013; 2(1):63-71. PubMed ID: 25019052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
    Xu XM; Zhang HJ
    World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
    Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
    Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics.
    Huang W
    Methods Mol Biol; 2017; 1617():57-67. PubMed ID: 28540676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.